Lifeline Biotechnologies Inc (LLBO)

[confirm]

Gold Std...
Post #30415
Well well well, let’s see what Leon Wang: Princeton University Phd researching cancer has to say about the iTBra-
“Skin patches are noninvasive, discrete, and potentially inexpensive enough that I could actually see use by common people on an ordinary basis. Specifically for Cyrcadia and iTBra™, the potential market is huge. There are over 700 million women worldwide between the ages of 20 and 70. In the United States alone, 38 million mammograms are preformed each year. Furthermore, the unacceptably high false positive rate of mammograms leads to an associated cost of over 4 billion dollars in unnecessary treatments annually in the US. If marketed correctly, iTBra™ is not only just a mammogram alternative, it could dominate the entire market
The Bottom Line
Cyrcadia sits on a very mature and proven technology that presents a solution to a “huge” market in which there is no current gold standard. This situation is unique in the startup field and I am very optimistic regarding the future success of iTBra™ and Cyrcadia.”

Tic toc tic...
PPS .22 ??? Or should I recalculate...let’s say on the upside

Full article link:
https://medium.com/startupreview/the-future-of-cancer-diagnostics-vol-3-e3188fefee41